194700 — Novarex Co Share Price
0.000.00%
Last trade - 00:00- KR₩153bn
- KR₩160bn
- KR₩302bn
- 79
- 79
- 51
- 84
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 5.59 | ||
| PEG Ratio (f) | 0.73 | ||
| EPS Growth (f) | 8.32% | ||
| Dividend Yield (f) | 1.73% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.73 | ||
| Price to Tang. Book | 0.74 | ||
| Price to Free Cashflow | 12.72 | ||
| Price to Sales | 0.53 | ||
| EV to EBITDA | 5.15 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.28% | ||
| Return on Equity | 9.24% | ||
| Operating Margin | 7.57% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 159,100.86 | 222,831.75 | 278,789.61 | 281,675.2 | 302,167.3 | 336,000 | 373,000 | 23% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +53.43 | +69.58 | +5.29 | -25.72 | +2.76 | +14.56 | +8.32 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Novarex Co Ltd is a Korea-based company principally engaged in the manufacturing and distribution of health functional foods. The Company manufactures and sells nutritional supplement products containing vitamins and minerals; individual recognition products which are helpful for body fat reduction, eye health, and joint health; lactic acid bacteria containing products used for skin condition improvement. The Company also produces and sells lutein zeaxanthin 164, supercritical Altig (rTG) omega 3, Boswellia for joint cartilage, lutein zeaxanthin, red ginseng concentrates and others. The Company distributes its products within domestic market to overseas markets.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- November 27th, 2008
- Public Since
- November 14th, 2018
- No. of Shareholders
- 16,515
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 17,702,216
- Address
- 94, CHEONGJU, 28220
- Web
- https://www.novarex.co.kr/
- Phone
- +82 432180510
- Auditors
- Samil PricewaterhouseCoopers
Upcoming Events for 194700
Novarex Co Ltd Annual Shareholders Meeting
Q1 2025 Novarex Co Ltd Earnings Release
Similar to 194700
Asia Seed Co
Korea Exchange - KOSDAQ
Bifido Co
Korea Exchange - KOSDAQ
BL PharmTech
Korea Exchange - KOSDAQ
ByOn Co
Korea Exchange - KOSDAQ
Cherrybro Co
Korea Exchange - KOSDAQ
FAQ
What is the Novarex Co share price?
As of Today at 21:21 UTC, shares in Novarex Co are trading at KR₩8,660. This share price information is delayed by 15 minutes.
How has the Novarex Co share price performed this year?
Shares in Novarex Co last closed at KR₩8,660 and the price had moved by -8.7% over the past 365 days. In terms of relative price strength the Novarex Co share price has underperformed the FTSE Developed Asia Pacific Index by -6.78% over the past year.
What are the analyst and broker recommendations for Novarex Co?
The overall consensus recommendation for Novarex Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Novarex Co dividend yield?
The Novarex Co dividend yield is 2.31% based on the trailing twelve month period.
Does Novarex Co pay a dividend?
Last year, Novarex Co paid a total dividend of KR₩200, and it currently has a trailing dividend yield of 2.31%. We do not have any data on when Novarex Co is to next pay dividends.
When does Novarex Co next pay dividends?
We do not have data on when Novarex Co is to next pay dividends. The historic dividend yield on Novarex Co shares is currently 2.31%.
How do I buy Novarex Co shares?
To buy shares in Novarex Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Novarex Co?
As of the previous close price of KR₩8,660, shares in Novarex Co had a market capitalisation of KR₩153bn.
Where are Novarex Co shares listed?
Here are the trading details for Novarex Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 194700
What kind of share is Novarex Co?
Based on an overall assessment of its quality, value and momentum Novarex Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Novarex Co share price forecast for 2025?
The analyst consensus target price for shares in Novarex Co is KR₩17,000. That is 96.3% above the last closing price of KR₩8,660.
Analysts covering Novarex Co currently have a consensus Earnings Per Share (EPS) forecast of KR₩1,431 for the next financial year.
Find out moreWhat is the trend in the Novarex Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Novarex Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -10.28%.
As of the last closing price of KR₩8,660, shares in Novarex Co were trading -5.57% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Novarex Co PE Ratio?
The Novarex Co PE ratio based on its reported earnings over the past 12 months is 5.59. The shares last closed at KR₩8,660.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Novarex Co?
Novarex Co's management team is headed by:
- Seok Hyeong Gwon - CEO